IL-12: a promising adjuvant for cancer vaccination Johanna E. PortieljeJan GratamaWim H. Kruit Review Pages: 133 - 144
Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 ganglioside Saroj BasakBrigitte BirebentDorothee Herlyn Original Article Pages: 145 - 154
A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer Yukio IwashitaKouichirou TaharaSeigo Kitano Original Article 06 February 2003 Pages: 155 - 161
Melphalan-induced up-regulation of B7–1 surface expression on normal splenic B cells Manjula DonepudiVladimir M. JovasevicMargalit B. Mokyr Original Article Pages: 162 - 170
Analysis of in vitro immunization: generation of cytotoxic T-lymphocytes against allogeneic melanoma cells with tumor lysate-loaded or tumor RNA-transfected antigen-presenting cells Alexey L. GlazyrinJune Kan-MitchellMalcolm S. Mitchell Original Article Pages: 171 - 178
Comparison of the efficacy of local treatment of equine sarcoids with IL-2 or cisplatin/IL-2 T. J. P. SpoormakersW. R. KleinW. Den Otter Original Article 04 February 2003 Pages: 179 - 184
Exposure to paclitaxel or vinblastine down-regulates CD11a and CD54 expression by P815 mastocytoma cells and renders the tumor cells resistant to killing by nonspecific cytotoxic T lymphocytes induced with anti-CD3 antibody Chuanli ZhaoMax MorganDavid W. Hoskin Original Article Pages: 185 - 193
Cryopreservation of mature monocyte-derived human dendritic cells for vaccination: influence on phenotype and functional properties Jörg WestermannIda J. KörnerAntonio Pezzutto Original Article Pages: 194 - 198
